Cell And Gene Articles, App Notes, Case Studies, & White Papers

  1. What FDA CRLs Reveal About E&L 2/18/2026

    FDA feedback shows E&L gaps still delay approvals. This preview flags common issues — from unknown compounds to weak tox data — and offers ways to strengthen E&L approaches and cut regulatory risk.

  2. The Connectivity Crisis Blocking AI Deployment 6/30/2026

    Disconnected systems and siloed data block analytics in life sciences manufacturing. Learn to bridge the infrastructure gap and build a connected foundation for scalable intelligence.

  3. Streamline AAV-Based Gene Therapies With Off-The-Shelf Plasmids 8/14/2025

    Standardized, well-characterized plasmids and streamlined platform processes can significantly accelerate viral vector development, improve consistency, and support scalable, high-quality gene therapy manufacturing.

  4. Evolving Landscape Of Payer Coverage For CGTs: Trends And Insights 1/20/2026

    Examine how proactive payer engagement and robust clinical evidence regarding comparative effectiveness and durability of response can overcome significant reimbursement barriers and enhance patient access.

  5. Anaerobic Cultivation Processes Of Probiotic Bacteria 12/18/2025

    Cultivate oxygen-sensitive probiotics with precision using real-time monitoring, microfluidic feeding, and pH control for reproducible growth and optimized microbiome and fermentation research.

  6. Relieving The Strain Of Publishing During Regulatory Registration 8/7/2024

    Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.

  7. Assessing Particle Generation In A Single-Use Mixing System 11/13/2025

    Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.

  8. Demonstrating IDS Value With Time-Based Metrics 6/10/2026

    Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.

  9. Decentralized And Community-Based Solutions Driving Women's Healthcare 9/24/2025

    Clinical trials should reflect the affected population by reducing participation barriers and bringing trials to patients to increase inclusion and improve real-world data.

  10. From LAL To rFC: The Evolution Of Endotoxin Testing 6/26/2026

    Protect patient safety and ensure regulatory compliance by implementing sensitive, reliable bacterial endotoxin testing as a critical component of pharmaceutical quality assurance.